Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 116

1.

The ESPOIR cohort: a ten-year follow-up of early arthritis in France: methodology and baseline characteristics of the 813 included patients.

Combe B, Benessiano J, Berenbaum F, Cantagrel A, Daurès JP, Dougados M, Fardellone P, Fautrel B, Flipo RM, Goupille P, Guillemin F, Le Loet X, Logeart I, Mariette X, Meyer O, Ravaud P, Rincheval N, Saraux A, Schaeverbeke T, Sibilia J.

Joint Bone Spine. 2007 Oct;74(5):440-5. Epub 2007 Jul 26.

PMID:
17905631
2.

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort.

Gottenberg JE, Miceli-Richard C, Ducot B, Goupille P, Combe B, Mariette X.

Arthritis Res Ther. 2009;11(4):R114. doi: 10.1186/ar2773. Epub 2009 Jul 23.

3.

Prospective cohort study of effects of infliximab on rheumatoid factor, anti-cyclic citrullinated peptide antibodies and antinuclear antibodies in patients with long-standing rheumatoid arthritis.

Bruns A, Nicaise-Roland P, Hayem G, Palazzo E, Dieudé P, Grootenboer-Mignot S, Chollet-Martin S, Meyer O.

Joint Bone Spine. 2009 May;76(3):248-53. doi: 10.1016/j.jbspin.2008.09.010. Epub 2009 Feb 8.

PMID:
19208451
4.

Predictive factors in early arthritis: long-term follow-up.

Schumacher HR Jr, Habre W, Meador R, Hsia EC.

Semin Arthritis Rheum. 2004 Feb;33(4):264-72.

PMID:
14978664
5.

Presence and utility of IgA-class antibodies to cyclic citrullinated peptides in early rheumatoid arthritis: the Swedish TIRA project.

Svärd A, Kastbom A, Reckner-Olsson A, Skogh T.

Arthritis Res Ther. 2008;10(4):R75. doi: 10.1186/ar2449. Epub 2008 Jul 4.

6.

Predicting factors for severity of rheumatoid arthritis: a prospective multicenter cohort study of 172 patients over 3 years.

Wagner E, Ammer K, Kolarz G, Krajnc I, Palkonyai E, Scherak O, Schödl C, Singer F, Temesvari P, Wottawa A.

Rheumatol Int. 2007 Sep;27(11):1041-8. Epub 2007 Apr 11.

PMID:
17429638
7.

Medication persistence over 2 years of follow-up in a cohort of early rheumatoid arthritis patients: associated factors and relationship with disease activity and with disability.

Pascual-Ramos V, Contreras-Yáñez I, Villa AR, Cabiedes J, Rull-Gabayet M.

Arthritis Res Ther. 2009;11(1):R26. doi: 10.1186/ar2620. Epub 2009 Feb 19.

8.
9.

Predictors of remission, normalized physical function, and changes in the working situation during follow-up of patients with early rheumatoid arthritis: an observational study.

Verschueren P, Esselens G, Westhovens R.

Scand J Rheumatol. 2009 May-Jun;38(3):166-72. doi: 10.1080/03009740802484846.

PMID:
19169906
10.

Relationship between serum hyaluronic acid level and disease activity in early rheumatoid arthritis.

Majeed M, McQueen F, Yeoman S, McLean L.

Ann Rheum Dis. 2004 Sep;63(9):1166-8.

11.

Early referral to the rheumatologist for early arthritis patients: evidence for suboptimal care. Results from the ESPOIR cohort.

Fautrel B, Benhamou M, Foltz V, Rincheval N, Rat AC, Combe B, Berenbaum F, Bourgeois P, Guillemin F.

Rheumatology (Oxford). 2010 Jan;49(1):147-55. doi: 10.1093/rheumatology/kep340. Epub 2009 Nov 23.

PMID:
19933784
12.

Antibodies to cyclic citrullinated protein and erythrocyte sedimentation rate predict hand bone loss in patients with rheumatoid arthritis of short duration: a longitudinal study.

Bøyesen P, Hoff M, Odegård S, Haugeberg G, Syversen SW, Gaarder PI, Okkenhaug C, Kvien TK.

Arthritis Res Ther. 2009;11(4):R103. doi: 10.1186/ar2749. Epub 2009 Jul 1.

13.

Contribution of PTPN22 1858T, TNFRII 196R and HLA-shared epitope alleles with rheumatoid factor and anti-citrullinated protein antibodies to very early rheumatoid arthritis diagnosis.

Goëb V, Dieudé P, Daveau R, Thomas-L'otellier M, Jouen F, Hau F, Boumier P, Tron F, Gilbert D, Fardellone P, Cornélis F, Le Loët X, Vittecoq O.

Rheumatology (Oxford). 2008 Aug;47(8):1208-12. doi: 10.1093/rheumatology/ken192. Epub 2008 Jun 5.

PMID:
18535030
14.

The DERAA HLA-DR alleles in patients with early polyarthritis: protection against severe disease and lack of association with rheumatoid arthritis autoantibodies.

Carrier N, Cossette P, Daniel C, de Brum-Fernandes A, Liang P, Ménard HA, Boire G.

Arthritis Rheum. 2009 Mar;60(3):698-707. doi: 10.1002/art.24353.

15.

Familial disease, the HLA-DRB1 shared epitope and anti-CCP antibodies influence time at appearance of substantial joint damage in rheumatoid arthritis.

Rojas-Villarraga A, Diaz FJ, Calvo-Páramo E, Salazar JC, Iglesias-Gamarra A, Mantilla RD, Anaya JM.

J Autoimmun. 2009 Feb;32(1):64-9. doi: 10.1016/j.jaut.2008.11.004. Epub 2008 Dec 30.

PMID:
19117726
16.

Early rheumatoid arthritis in Italy: study of incidence based on a two-level strategy in a sub-area of Florence (Scandicci-Le Signe).

Benucci M, Cammelli E, Manfredi M, Saviola G, Baiardi P, Mannoni A; Associazione Medici-Scandicci.

Rheumatol Int. 2008 Jun;28(8):777-81. doi: 10.1007/s00296-008-0527-6. Epub 2008 Jan 30.

PMID:
18231795
17.
18.

[The role of anti-cyclic citrullinated peptide (anti-CCP) antibodies in serologic diagnosis and evaluation of disease activity in rheumatoid arthritis].

Aridoğan BC, Kaya S, Savaş S, Cetin ES, Akkuş S, Demirci M.

Mikrobiyol Bul. 2008 Oct;42(4):669-74. Turkish.

PMID:
19149089
19.

Trends towards an improved disease state in rheumatoid arthritis over time: influence of new therapies and changes in management approach: analysis of the EMECAR cohort.

González-Alvaro I, Descalzo MA, Carmona L; Estudio de la Morbilidad y Expresión Clínica de la Artritis Reumatoide Study Group.

Arthritis Res Ther. 2008;10(6):R138. doi: 10.1186/ar2561. Epub 2008 Nov 26.

20.

Easy and accurate diagnosis of rheumatoid arthritis using anti-cyclic citrullinated peptide 2 antibody, swollen joint count, and C-reactive protein/rheumatoid factor.

Yamane T, Hashiramoto A, Tanaka Y, Tsumiyama K, Miura Y, Shiozawa K, Chihara K, Shiozawa S.

J Rheumatol. 2008 Mar;35(3):414-20. Epub 2008 Jan 15.

PMID:
18203327

Supplemental Content

Support Center